Latest news
Loading news…
PROCAGEN is a genetic analysis service company that predicts the risk of prostate cancer through genetic analysis.
PROCAGEN was acquired by Invites Biocore in 2022 for $10M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Seongnam, Kyonggi-do, South Korea
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to PROCAGEN
Loading news…
FAQs about PROCAGEN
People who checked this page also checked these
Browse the full Acquirezy directory.